Regulators of innate immunity as novel targets for panviral therapeutics

Interferons (IFNs) have long been used as an immunomodulatory therapy for a large array of acute and chronic viral infections. However, IFN therapies have been plagued by severe side effects. The discovery of pathogen recognition receptors (PRR) rejuvenated the interest for immunomodulatory therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Es-Saad, Salwa, Tremblay, Nicolas, Baril, Martin, Lamarre, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102864/
https://www.ncbi.nlm.nih.gov/pubmed/23017246
http://dx.doi.org/10.1016/j.coviro.2012.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102864/
https://www.ncbi.nlm.nih.gov/pubmed/23017246
http://dx.doi.org/10.1016/j.coviro.2012.08.009

Ejemplares similares